Ignet
Search (e.g., vaccine, IFNG): Help
About
Home
Introduction
Statistics
Programs
Dignet
Gene
GenePair
BioSummarAI
Help & Docs
Documents
Help
FAQs
Links
Acknowledge
Disclaimer
Contact Us
UM Logo

UMMS Logo

UMMS Logo

Gene Information

Gene symbol: MIA

Gene name: melanoma inhibitory activity

HGNC ID: 7076

Synonyms: CD-RAP

Related Genes

# Gene Symbol Number of hits
1 APC 1 hits
2 ERVWE1 1 hits
3 GP5 1 hits
4 GSTA1 1 hits
5 GSTCD 1 hits
6 PRNT 1 hits
7 RNASE1 1 hits
8 RNASE3 1 hits
9 S100B 1 hits
10 VTN 1 hits

Related Sentences

# PMID Sentence
1 8361775 Antibody-dependent MIA titres were much lower than for APC-dependent MIA.
2 16921881 One hundred and ninety-one sera from horses that recently were exposed to West Nile virus (WNV) by either vaccination or natural infection or that were not vaccinated and remained free of infection were used to evaluate fluorescent microsphere immunoassays (MIAs) incorporating recombinant WNV envelope protein (rE) and recombinant nonstructural proteins (rNS1, rNS3, and rNS5) for detection of equine antibodies to WNV.
3 16921881 The NS protein-based MIA were all less sensitive than either the rE MIA or PRNT (sensitivity 0-48.0), although the rNSI MIA distinguished horses vaccinated with the recombinant WNV vaccine from those that were immunized with the inactivated WNV vaccine (P < 0.0001) or naturally infected with WNV (P < 0.0001).
4 16921881 One hundred and ninety-one sera from horses that recently were exposed to West Nile virus (WNV) by either vaccination or natural infection or that were not vaccinated and remained free of infection were used to evaluate fluorescent microsphere immunoassays (MIAs) incorporating recombinant WNV envelope protein (rE) and recombinant nonstructural proteins (rNS1, rNS3, and rNS5) for detection of equine antibodies to WNV.
5 16921881 The NS protein-based MIA were all less sensitive than either the rE MIA or PRNT (sensitivity 0-48.0), although the rNSI MIA distinguished horses vaccinated with the recombinant WNV vaccine from those that were immunized with the inactivated WNV vaccine (P < 0.0001) or naturally infected with WNV (P < 0.0001).
6 17661202 A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.
7 18032597 The GP5(55-98) MIA and VNT outcomes correlated significantly (r = 0.84; P < 0.0001).
8 18032597 Although the GP5(55-98) MIA is less sensitive than the standard VNT, it has the potential to provide a rapid, convenient, and more economical test for screening equine sera for the presence of antibodies to EAV, with the VNT then being used as a confirmatory assay.
9 18032597 The GP5(55-98) MIA and VNT outcomes correlated significantly (r = 0.84; P < 0.0001).
10 18032597 Although the GP5(55-98) MIA is less sensitive than the standard VNT, it has the potential to provide a rapid, convenient, and more economical test for screening equine sera for the presence of antibodies to EAV, with the VNT then being used as a confirmatory assay.
11 23740920 We compared the measurement of human papillomavirus (HPV)-specific serum antibody levels with the virus-like-particle multiplex immunoassay (VLP-MIA), competitive Luminex immunoassay (cLIA), and glutathione S-transferase (GST) L1-based MIA.
12 23740920 However, an adaptation of the GST L1-based MIA resulted in an improved correlation with both cLIA and VLP-MIA.
13 23740920 We compared the measurement of human papillomavirus (HPV)-specific serum antibody levels with the virus-like-particle multiplex immunoassay (VLP-MIA), competitive Luminex immunoassay (cLIA), and glutathione S-transferase (GST) L1-based MIA.
14 23740920 However, an adaptation of the GST L1-based MIA resulted in an improved correlation with both cLIA and VLP-MIA.